BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Huifeng Bio-Pharmaceutical Technology, Inc. to Attend 2010 Maxim Group Growth Conference


11/11/2010 11:40:23 AM

China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced that Huifeng CEO Jing'an Wang, will make a presentation at the 2010 Maxim Group Growth Conference to be held on November 18, 2010 at the Grand Hyatt Hotel in New York, NY. The Company presentation details are provided below:

Date: November 18, 2010

Presentation time: 9:00 am -9:30 am

Location: Edison/Palace of Grand Hyatt New York

The 4th annual Maxim Group Growth Conference is a senior level, interactive conference experience designed to meet the needs of our institutional clients. It combines company presentations, break-out sessions and management 1-on-1 meetings to assist clients with gaining an in-depth perspective on the issues affecting the growth of presenting companies.

This one-day event will feature more than 80 presentations across six designated tracks from a diverse selection of both domestic and international companies. For more information about the conference and registration, please visit http://www.maximgrp.com/growthconf/index.php

To request a one-on-one meeting or to be added to Huifeng's email list, please contact Kevin Fickle at Kevin@nuwagroup.com or call 415-332-7200.

To be added to the Company's email distribution for future news releases, please send your request to Kevin@nuwagroup.com.

About Huifeng Bio-Pharmaceutical Technology, Inc.

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. More information can be found on the Company's web site at: http://www.hfgb.cn/


For more information, please contact:





Investor Relations:


NUWA GROUP


Mr. Kevin Fickle


Tel: +1-925-330-8315


Email: Kevin@nuwagroup.com






Company Contact:


Huifeng Bio-Pharmaceutical Technology, Inc.


Ms. Bing He


Tel: +86-139-9195-4170


Email: bing@xahuifeng.com





SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES